95 related articles for article (PubMed ID: 9403003)
1. Growth inhibition of B-cell precursor acute lymphoblastic leukemia cell lines by monocytes: a role for prostaglandin E2.
Giordano L; Moldwin RL; Downie PA; Goldberg A; Gupta R; Allen R; Aithal NH; Kim DH; Le Moine PJ; Smith SD
Leuk Res; 1997 Oct; 21(10):925-32. PubMed ID: 9403003
[TBL] [Abstract][Full Text] [Related]
2. Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia.
Zhang LQ; Downie PA; Goodell WR; McCabe NR; LeBeau MM; Morgan R; Sklar J; Raimondi SC; Miley D; Goldberg A
Leukemia; 1993 Nov; 7(11):1865-74. PubMed ID: 8231254
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of human B cell precursor-leukemia cell lines.
Matsuo Y; Drexler HG
Leuk Res; 1998 Jul; 22(7):567-79. PubMed ID: 9680106
[TBL] [Abstract][Full Text] [Related]
4. Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model.
Richartz N; Duthil E; Ford A; Naderi EH; Bhagwat S; Gilljam KM; Burman MM; Ruud E; Blomhoff HK; Skah S
Blood Adv; 2019 Nov; 3(21):3181-3190. PubMed ID: 31698450
[TBL] [Abstract][Full Text] [Related]
5. Protumoral role of monocytes in human B-cell precursor acute lymphoblastic leukemia: involvement of the chemokine CXCL10.
Lee Y; Chittezhath M; André V; Zhao H; Poidinger M; Biondi A; D'Amico G; Biswas SK
Blood; 2012 Jan; 119(1):227-37. PubMed ID: 22058116
[TBL] [Abstract][Full Text] [Related]
6. Effect of tumor necrosis factor-alpha on the proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemia (BCP-ALL): studies of primary leukemic cells and BCP-ALL cell lines.
Zhou MX; Findley HW; Ma LH; Zaki SR; Hill T; Hamid M; Hooper WC; Ragab AH
Blood; 1991 May; 77(9):2002-7. PubMed ID: 2018837
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
Lader CS; Flanagan AM
Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL.
Naderi EH; Ugland HK; Diep PP; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Blood; 2013 Mar; 121(10):1805-13. PubMed ID: 23299313
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells.
Makrynikola V; Kabral A; Bradstock KF
Exp Hematol; 1991 Aug; 19(7):674-9. PubMed ID: 1893954
[TBL] [Abstract][Full Text] [Related]
10. Plasma prostaglandin levels and circulating fuel levels in rats with diabetic ketoacidosis: effects of cyclooxygenase inhibitors and of alpha and beta adrenergic blockade.
Axelrod L; Cornelius P
Prostaglandins; 1984 Sep; 28(3):333-52. PubMed ID: 6440213
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.
LeGrand A; Fermor B; Fink C; Pisetsky DS; Weinberg JB; Vail TP; Guilak F
Arthritis Rheum; 2001 Sep; 44(9):2078-83. PubMed ID: 11592370
[TBL] [Abstract][Full Text] [Related]
12. Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells.
Ashley DM; Bol SJ; Kannourakis G
Leuk Res; 1995 Feb; 19(2):113-20. PubMed ID: 7869739
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms.
Walton LJ; Franklin IJ; Bayston T; Brown LC; Greenhalgh RM; Taylor GW; Powell JT
Circulation; 1999 Jul; 100(1):48-54. PubMed ID: 10393680
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.
Naderi EH; Skah S; Ugland H; Myklebost O; Sandnes DL; Torgersen ML; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Mol Cancer; 2015 Jan; 14(1):14. PubMed ID: 25623255
[TBL] [Abstract][Full Text] [Related]
15. Intracellular measurement of prostaglandin E2: effect of anti-inflammatory drugs on cyclooxygenase activity and prostanoid expression.
Horton JK; Williams AS; Smith-Phillips Z; Martin RC; O'Beirne G
Anal Biochem; 1999 Jun; 271(1):18-28. PubMed ID: 10361000
[TBL] [Abstract][Full Text] [Related]
16. Lipoperoxidation and T-cell leukemia of childhood. Effects of indomethacin.
Brown RE; Alade SL; Wu MC; Wu FM; Bowman WP
Cancer; 1989 Nov; 64(10):2090-5. PubMed ID: 2804898
[TBL] [Abstract][Full Text] [Related]
17. Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia.
Matsuo Y; Drexler HG; Takeuchi M; Orita K
Leuk Lymphoma; 1999 Nov; 35(5-6):513-26. PubMed ID: 10609789
[TBL] [Abstract][Full Text] [Related]
18. Possible Contribution of Prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells.
Banner KH; Hoult JR; Taylor MN; Landells LJ; Page CP
Biochem Pharmacol; 1999 Nov; 58(9):1487-95. PubMed ID: 10513992
[TBL] [Abstract][Full Text] [Related]
19. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
[TBL] [Abstract][Full Text] [Related]
20. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH
Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
